Drreddys Laboratories | RDY - 营业利润

金融业

INR

INR 6.26B

现金及等价物

INR 18.66B

INR 40.46B

INR 3.31B

INR 1.76B

INR 67.73B

股息收益率

INR 0.65

INR 16.37B

INR 21.59B

INR 27.81K

EPS每股收益

INR 0.16

股本和储备

INR 4.14B

INR 46.81B

债务利息支出

INR 944M

INR 796M

INR 129.19M

INR 2.16B

INR 12.1B

INR 72.94B

INR 14.33B

普通股股本

INR 832.57M

18.27

INR 15.43B

INR 87.27B

销售和管理费用

INR 26.92B

INR 79.01B

贸易债权人

INR 454.04M

应收帐款人

INR 1.41B

	营业利润	更改		日
ANI Pharmaceuticals	USD 29.13M		6.3M	2025-12
Aurora Cannabis	CAD -35.79M		19.88M	2025-12
Bayer	EUR 1.11B		1.65B	2025-12
Canopy Growth	CAD -12.66M		1.64M	2025-12
Cipla	INR 9.77B		6.21B	2025-12
Corcept Therapeutics	USD 4.49M		5.73M	2025-12
Drreddys Laboratories	INR 14.33B		2.51B	2025-12
GlaxoSmithKline	GBP 1.44B		1.35B	2025-12
Hikma Pharmaceutical	USD 348M		161M	2025-12
Lonza	CHF 673M		243M	2025-06
Novartis	USD 4.06B		437M	2025-12
Pacira	USD 3.19M		9.96M	2025-12
Phibro Animal Health	USD 54.99M		2.36M	2025-12
Prestige Brands	USD 82.49M		2.82M	2025-12
Richter Gedeon	HUF 63.58B		6.08B	2025-09
Sun Pharmaceuticals	INR 33.67B		49.9M	2025-09
Supernus Pharmaceuticals	USD 13.82M		74.01M	2025-12
Teva Pharmaceutical Industries	USD 487M		581M	2025-12